Daiichi Sankyo Europe and Esperion Announce Validation of theMarketing Authorisation Application (MAA) for Bempedoic Acid and theBempedoic…
Ezetimibe Fixed Dose Combination Tablet
Munich and Ann Arbor, Michigan (ots/PRNewswire) - * Application is based on results of a robust development programme,
which demonstrated that bempedoic acid was well tolerated and efficacious for chronic use
* Bempedoic acid is a first-in-class, oral, once-daily ATP Citrate Lyase (ACL) inhibitor that reduces cholesterol and fatty acid synthesis in the liver
* Bempedoic acid expands Daiichi Sankyo Europe's commitment to cardiovascular care and the development of!-->!-->!-->…